查詢結果分析
相關文獻
- The use of Atracurium in Chinese Myasthenic Patients Undergoing Thymectomy
- 重肌無力症之受體抗體檢查
- 大餐之後,四肢無力甲狀腺毒性週期性肌無力症簡介
- 以免疫吸附血漿析離療法治療重症肌無力症之評估
- 重症肌無力症危象的加護照顧
- Thymomatous Myasthenia Gravis
- 重症肌無力症之血漿分離術療法
- Coexistence of Epilepsy, Myasthenia Gravis and Psoriasis Vulgaris
- Plasmapheresis Based on Molecular Immunology in Myasthenias
- 重症肌無力危象的加護照顧
頁籤選單縮合
題名 | Mycophenolate Mofetil Therapy in Taiwanese Myasthenia Gravis=臺灣肌無力症的Mycophenolate Mofetie療法 |
---|---|
作者 | 葉建宏; 陳威宏; 邱浩彰; Yeh, Jiann-horng; Chen, Wei-hung; Chiu, Hou-chang; |
期刊 | Acta Neurologica Taiwanica |
出版日期 | 20080900 |
卷期 | 17:3 2008.09[民97.09] |
頁次 | 頁167-171 |
分類號 | 415.9413 |
語文 | eng |
關鍵詞 | 肌無力症; Immunosuppression; Myasthenia gravis; Mycophenolate mofetil; |
英文摘要 | Background: Mycophenolate mofetil (MM) has been successfully used for the treatment of immune-mediated diseases, including myasthenia gravis (MG). We compare our experience treating Taiwanese myasthenic patients with MM to analogous Caucasian series Methods: From October 2003 to April 2008, we treated 6 myasthenic patients with MM for at least one year at Shin Kong Wu Ho-Su Memorial Hospital. The inclusion criteria for MM treatment included poor responses to previous treatment or intolerance to the side effects of previous immunosuppressive therapies. The MM was given orally with a dose of 1 g twice per day. Mandatory surveillance laboratory studies and clinical assessment were performed periodically. Results: Three of our six patients responded well to MM treatment in terms of improvement in MG score and achievement of minimal manifestation status. The fourth patient showed delayed onset of response 12 months after commencement of MM treatment. Steroid-sparing effect could be demonstrated in 4 patients. The overall response rate (66%) was slightly lower than that reported for Caucasian series. Clinical improvement generally began in the second to four months. MM was well tolerated. Conclusion: MM was well tolerated by our six treated patients. Although the clinical response was modest, MM has its advantage of a relatively rapid response onset and steroid-sparing effect. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。